Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India

[ad_1] The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The market share of India’s most popular weight‑loss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmakers flooded the market with lower‑priced copies. Eli Lilly’s Indian market share in the GLP‑1 category…

Read More

After the Iran war, what’s next for tech?

[ad_1] This report is from this week’s The Tech Download newsletter. Like what you see? You can subscribe here. The past week has seen some progress, albeit uneasy and stilted, being made towards ending the Iran war. A two-week ceasefire was agreed on Wednesday, and while it looks fragile, hopes of the conflict approaching a close…

Read More

Ukraine, Iran wars challenge defense’s playbook

[ad_1] Warfare is undergoing a fundamental shift where tech with big price tags is being challenged by a more agile, decentralized model, spearheaded by Silicon Valley-backed start-ups, industry watchers told CNBC. The traditional defense model — notorious for development cycles that can span decades — is coming under increasing pressure. Companies are instead betting on…

Read More